Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-009491

Cardiff Oncology, Inc. · CRDF

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Feb 25, 2015
Accepted (ET)
Feb 27, 2015 · 7:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001213037

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $.0001 par value per shareF1,F2,F3Feb 25, 2015P105,142$5.12A2,692,443ISee footnotes
Common Stock, $.0001 par value per shareF4,F2,F3Feb 26, 2015P78,801$5.42A2,771,244ISee footnotes
Common Stock, $.0001 par value per shareF5,F2,F3Feb 27, 2015P79,343$5.62A2,850,587ISee footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses